CBIO vs PEP · rev $1.0M vs P/E 22, rev $43.62B
Crescent Biopharma, Inc. (CBIO) versus PepsiCo Inc (PEP) — a side-by-side from cached financials, not a winner call.
Crescent Biopharma, Inc. (CBIO) is a biotechnology company listed on NASDAQ.
PepsiCo Inc (PEP) is a beverages - non-alcoholic company listed on NASDAQ. It is led by Ramon Laguarta.
Latest reported CBIO revenue for 2026-06-30 was $1.0M. Net income was -$48.1M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. CBIO currently screens at market cap $491.3M.
Latest reported PEP revenue for 2026-06-13 was $43.62B. Net income was $5.31B. PEP currently screens at market cap $193.55B and trailing P/E 22.2.
CBIO currently screens at market cap $491.3M. PEP currently screens at market cap $193.55B and trailing P/E 22.2.
Not investment advice. Open the CBIO and PEP stock pages for the full models.
Not investment advice.